A mixed methods pilot randomised controlled trial to develop and evaluate the feasibility of a Mediterranean diet and lifestyle education intervention 'THINK-MED' among people with cognitive impairment.

Cognitive impairment Feasibility Intervention Mediterranean diet Prevention

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
04 Jan 2021
Historique:
received: 22 01 2020
accepted: 30 11 2020
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 5 1 2021
Statut: epublish

Résumé

Accumulating evidence supports the role of a Mediterranean diet (MD) in cognition, with a greater adherence to a MD associated with reduced dementia risk. It is important to understand how best to achieve behaviour change towards a MD, particularly in non-Mediterranean and high-risk populations. The aim of this study was to evaluate the feasibility of a MD and lifestyle education intervention (THINK-MED) among older adults with cognitive impairment. Qualitative interviews (Phase I), conducted with mild cognitive impairment (MCI) participants, evaluated the intervention materials to allow refinement before pilot testing. THINK-MED was a 12-month, pilot RCT (Phase II) whereby MCI participants were randomised into one of three groups: education on one occasion vs education staged and supported by a dietitian vs control. The primary outcome was a change in MD score. Secondary outcome measurements were collected to gather data on variability of the outcomes to inform a full trial power calculation and to test their acceptability. Slower recruitment rates necessitated a change in primary outcome to a revised focus primarily on feasibility. A sub-study of the same THINK-MED intervention and data collection measures was also conducted among community-dwelling participants with subjective cognitive impairment (SCI) (NCT03569319). A total of 20 participants (n = 15 MCI; n = 5 SCI) were enrolled in the THINK-MED study. However, there were 10 (50%) participants (n = 9 MCI; n = 1 SCI) who withdrew from the study. Although, those who remained in the intervention rated and evaluated their experience as generally positive, recruitment and retention, especially from a MCI population, was extremely challenging. This highlights the complex needs of this heterogeneous clinical cohort. Recruiting participants from a community-based sample with SCI was more feasible, reaching a wider audience in a shorter time period. There were challenges relating to data collection and incompleteness, with the occurrence of missing data particularly among the questionnaire-based assessments. Owing to the challenges with recruitment and retention of older adults with cognitive impairment in this study, it is difficult to confirm if this intervention is feasible. This research has highlighted considerations for a future trial, including a review of the recruitment strategies used and prioritisation of the outcome measures assessed. Clinical trials registration NCT03265522 / NCT03569319.

Sections du résumé

BACKGROUND BACKGROUND
Accumulating evidence supports the role of a Mediterranean diet (MD) in cognition, with a greater adherence to a MD associated with reduced dementia risk. It is important to understand how best to achieve behaviour change towards a MD, particularly in non-Mediterranean and high-risk populations. The aim of this study was to evaluate the feasibility of a MD and lifestyle education intervention (THINK-MED) among older adults with cognitive impairment.
METHODS METHODS
Qualitative interviews (Phase I), conducted with mild cognitive impairment (MCI) participants, evaluated the intervention materials to allow refinement before pilot testing. THINK-MED was a 12-month, pilot RCT (Phase II) whereby MCI participants were randomised into one of three groups: education on one occasion vs education staged and supported by a dietitian vs control. The primary outcome was a change in MD score. Secondary outcome measurements were collected to gather data on variability of the outcomes to inform a full trial power calculation and to test their acceptability. Slower recruitment rates necessitated a change in primary outcome to a revised focus primarily on feasibility. A sub-study of the same THINK-MED intervention and data collection measures was also conducted among community-dwelling participants with subjective cognitive impairment (SCI) (NCT03569319).
RESULTS RESULTS
A total of 20 participants (n = 15 MCI; n = 5 SCI) were enrolled in the THINK-MED study. However, there were 10 (50%) participants (n = 9 MCI; n = 1 SCI) who withdrew from the study. Although, those who remained in the intervention rated and evaluated their experience as generally positive, recruitment and retention, especially from a MCI population, was extremely challenging. This highlights the complex needs of this heterogeneous clinical cohort. Recruiting participants from a community-based sample with SCI was more feasible, reaching a wider audience in a shorter time period. There were challenges relating to data collection and incompleteness, with the occurrence of missing data particularly among the questionnaire-based assessments.
CONCLUSIONS CONCLUSIONS
Owing to the challenges with recruitment and retention of older adults with cognitive impairment in this study, it is difficult to confirm if this intervention is feasible. This research has highlighted considerations for a future trial, including a review of the recruitment strategies used and prioritisation of the outcome measures assessed.
TRIAL REGISTRATION BACKGROUND
Clinical trials registration NCT03265522 / NCT03569319.

Identifiants

pubmed: 33390187
doi: 10.1186/s40814-020-00738-3
pii: 10.1186/s40814-020-00738-3
pmc: PMC7780397
doi:

Banques de données

ClinicalTrials.gov
['NCT03569319', 'NCT03265522']

Types de publication

Journal Article

Langues

eng

Pagination

3

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J000388/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202097/Z/16/Z
Pays : United Kingdom

Références

Health Educ Res. 2000 Oct;15(5):635-47
pubmed: 11184222
Arch Neurol. 2009 Feb;66(2):216-25
pubmed: 19204158
Dement Geriatr Cogn Disord. 2010;29(5):413-23
pubmed: 20502015
J Acad Nutr Diet. 2012 Jun;112(6):816-23
pubmed: 22709809
PLoS One. 2012;7(8):e43134
pubmed: 22905215
Clin Geriatr Med. 2013 Nov;29(4):753-72
pubmed: 24094295
Eur J Clin Nutr. 1999 Apr;53(4):298-308
pubmed: 10334656
Epidemiology. 2015 Sep;26(5):758-68
pubmed: 26133024
J Alzheimers Dis. 2018;62(2):579-581
pubmed: 29480202
JAMA Intern Med. 2015 Jul;175(7):1094-1103
pubmed: 25961184
Mech Ageing Dev. 2014 Mar-Apr;136-137:59-69
pubmed: 24333791
Am J Clin Nutr. 2018 Mar 1;107(3):389-404
pubmed: 29566197
Nutrients. 2018 Oct 20;10(10):
pubmed: 30347812
Lancet. 2015 Jun 6;385(9984):2255-63
pubmed: 25771249
Aging Ment Health. 2013;17(3):276-86
pubmed: 23402379
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Neurology. 2018 May 15;90(20):e1789-e1798
pubmed: 29653991
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Epidemiology. 2013 Jul;24(4):479-89
pubmed: 23680940
J Clin Epidemiol. 1998 Nov;51(11):1025-36
pubmed: 9817120
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Prev Alzheimers Dis. 2014 Jun;1(1):23-32
pubmed: 25237654
J Alzheimers Dis. 2014;39(2):271-82
pubmed: 24164735
Alzheimers Dement. 2017 Feb;13(2):168-177
pubmed: 27461490
Ageing Res Rev. 2017 May;35:222-240
pubmed: 27713095
J Med Food. 2013 Apr;16(4):343-50
pubmed: 23514229
J Am Geriatr Soc. 2008 Dec;56(12):2340-8
pubmed: 19093934
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
Int J Nurs Stud. 2013 May;50(5):587-92
pubmed: 23159157
Transl Psychiatry. 2018 Oct 30;8(1):238
pubmed: 30375373
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Neurology. 2013 Apr 30;80(18):1684-92
pubmed: 23628929
Prev Med. 2002 Feb;34(2):153-61
pubmed: 11817910
Neurology. 2015 Nov 17;85(20):1744-51
pubmed: 26491085
Exp Gerontol. 2013 Dec;48(12):1443-8
pubmed: 24126083
Alzheimers Dement (Amst). 2015 Jul 02;1(3):328-33
pubmed: 27239514
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Ann Neurol. 2006 Jun;59(6):912-21
pubmed: 16622828
Age Ageing. 1996 Mar;25(2):113-20
pubmed: 8670538
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Lancet Neurol. 2017 Dec;16(12):965-975
pubmed: 29097166
J Nutr Health Aging. 2015 Dec;19(10):1019-22
pubmed: 26624214
J Nutr Health Aging. 2014 Apr;18(4):411-8
pubmed: 24676323
Am J Geriatr Psychiatry. 2012 Jul;20(7):635-9
pubmed: 21937919
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1318-25
pubmed: 23670794
Neurology. 2017 Jan 31;88(5):449-455
pubmed: 28053008
Sci Rep. 2017 Jan 23;7:41317
pubmed: 28112268
Trials. 2014 Jul 05;15:267
pubmed: 24996765
J Am Geriatr Soc. 2017 Aug;65(8):1857-1862
pubmed: 28440854
Transl Psychiatry. 2012 Oct 02;2:e164
pubmed: 23032941
Alzheimers Dement. 2015 Sep;11(9):1023-31
pubmed: 26190494
Br J Nutr. 2018 Dec;120(12):1388-1405
pubmed: 30409231
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Online J Public Health Inform. 2012;4(3):
pubmed: 23569653
Am J Clin Nutr. 2013 Feb;97(2):369-76
pubmed: 23283500
Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):726-33
pubmed: 24071781
BJPsych Open. 2018 Jun 27;4(4):208-214
pubmed: 29988927
JAMA. 2009 Aug 12;302(6):638-48
pubmed: 19671905
Stat Methods Med Res. 2016 Jun;25(3):1057-73
pubmed: 26092476
J Nutr Health Aging. 2015 Mar;19(3):305-12
pubmed: 25732216
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248

Auteurs

Andrea M McGrattan (AM)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK. andrea.mcgrattan@newcastle.ac.uk.

Claire T McEvoy (CT)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Aswathy Vijayakumar (A)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Sarah E Moore (SE)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Charlotte E Neville (CE)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Bernadette McGuinness (B)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Michelle C McKinley (MC)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Jayne V Woodside (JV)

Centre for Public Health, Queens University Belfast, Belfast, BT12 6BJ, UK.

Classifications MeSH